Users online: 3961    [ij] [ij] [ij] 
Email id

Indian Journal of Animal Research
Year : 2015, Volume : 49, Issue : 1
First page : ( 127) Last page : ( 131)
Print ISSN : 0367-6722. Online ISSN : 0976-0555.
Article DOI : 10.5958/0976-0555.2015.00026.6

Isolation and characterization of Stromelysin-3(MMP-11) like protein from a case of mammary carcinoma in a dog

Sahoo Sujata*, Kataria Meena, Maiti S.K.1

Division of Animal Biochemistry, Indian Veterinary Research Institute, Izatnagar, Bareilly-243 122, India

1Division of Veterinary Surgery, IVRI, Izatnagar

*Corresponding author’ e-mail: sujatasahoo@cife.edu.in

Online published on 21 February, 2015.


Stromelysin-3(MMP-11) is a matrix-metalloproteinase known to be over expressed in invasive tumors of human origin and suppose to have a potential role in metastasis. Dog mammary tumors are usually very invasive. Thus to characterize dog stromelysin-3, mammary tumor tissue (papillary adenocarcinoma) was used to isolate the protein by using affinity chromatography tools including Cibacron-Blue 3GA-CL Agarose, gelatin Sepharose, and heparin Sepharose columns. Western blotting with antihuman stromelysin-3 antibody was done for identification. The result showed a heavier (120kDa) protein than the expected size of stromelysin-3. Western blot analysis of the crude sample did not show any other reactive bands. Under reducing condition, the protein size remained intact. The stromelysin-3 like protein showed mild caseinolytic activity, which increased by activators like APMA and trypsin. Whereas, its activity decreased when inhibitors like EDTA, 1, 10-Phenanthroline and TIMP-1 were used suggesting the requirement of calcium and zinc for enzyme activity just like any other metalloproteinase.



Metastasis, MMP-11, Papillary adenocarcinoma, Stromelysin-3, TIMP-1.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
348,677,553 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.